this is interesting... it is actually NovaQuest affiliated company Quintiles that is responsible for the market access strategy, pricing and product management from Bronchitol in EU. so if they are unhappy then they should not be shaking a finger at PXS- there is more to the communication that we are presently aware of IMO. see links below:
